In partnership with The L Suite, Wilson Sonsini will host an exclusive dinner for Chief Legal Officers and General Counsels from the biotech industry. This intimate program is designed to foster candid dialogue and meaningful connections.
Partner Danielle Naftulin will lead the discussion on "The Biotech GC in the Boardroom: Preparation, Pressure Points, and Closed Sessions" with Galya Blachman, Chief Legal Officer and Head of Business Development at Enliven Therapeutics. Rachel Nagashima and Christina Poulsen will also attend.
This event is by invitation for L Suite members only.
Tomoko Beytien
tbeytien@wsgr.com
Danielle Naftulin is a partner in the Palo Alto office of Wilson Sonsini with over 25 years of experience advising emerging companies and venture capital investors on a broad range of corporate transactions. Her practice focuses on the representation of high-growth life sciences and technology companies and their investors in formation and financing matters, as well as mergers and acquisitions, recapitalizations, spinouts, and general corporate matters. She has also represented clients in connection with initial public offerings and other public financing and strategic transactions.
Prior to joining the firm, Danielle was a partner in the business department at Cooley LLP in Palo Alto. She is an active member of the National Venture Capital Association’s General Counsel Advisory Board and a regular speaker on emerging companies and venture capital for Practising Law Institute, various law schools, and other organizations.